Related Experiment Video
Updated: Sep 8, 2026

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
DRP-1 and circadian rhythms: deciphering their impact on PCOS
Aparna Eledath Kolasseri1, Indrani Paramasivan Latha Laxmi1, Sivaraman Jayanthi1
1School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
Abstract:
Polycystic ovarian syndrome (PCOS) is a complex reproductive disorder that impacts metabolic, endocrine, and circadian functions. Disruption in circadian rhythm can trigger PCOS due to an elevation in oxidative and inflammatory markers. Studies reveal that the increase in oxidative damage can occur due to defects in mitochondrial dynamics, through Dynamin-related protein 1 (DRP-1), in the development of PCOS. However, the mechanism of pathogenesis of PCOS through circadian rhythm and mitochondrial dynamics remains unclear. DRP-1 is a crucial regulator of mitochondrial fission, influencing ovarian physiology and steroidogenesis, contributing to hormonal imbalances in PCOS. Additionally, DRP-1 plays a role in the hypothalamus, where it links mitochondrial dynamics to circadian rhythms, suggesting a potential connection between circadian disruptions and PCOS symptoms. This review explores the function of DRP-1 in ovarian steroidogenesis and hypothalamic pathways, examining its contribution to PCOS-related complications. Understanding the effects of DRP-1 on mitochondrial function and circadian rhythm could contribute to potential therapeutic targets focused on mitochondrial health and circadian regulation in PCOS.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Management of Insomnia
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

